Glutamine antagonism selectively upregulated OXPHOS in tumor-infiltrating CD8+ cells via an increased activity of acyl-coenzyme A (CoA) synthetase short-chain family member 1 (ACSS1), allowing the fueling of the TCA cycle through acetate [160]. Here, CD8A is linked to neoplasm.